NeurotechMagProGet access
Funding Round

Insellar Raises €400K Pre-Seed for Brain-Computer Interface Targeting Treatment-Resistant Depression

Startbase4/16/2026·04/16/26🇪🇺 Europe

Summary

Berlin-based Insellar, founded in July 2025, has raised a €400,000 pre-seed round from IBB Ventures, business angels and experts in neurosurgery, psychiatry and neurotechnology. The company is developing a patented brain-computer interface for treatment-resistant depression. The money is for preclinical proof of concept and prototype validation, followed by preparation for clinical development in Europe and the USA.

Why it matters

It is an early-stage European company aiming a BCI at treatment-resistant depression, a psychiatric rather than motor use. The round is small and the device is still preclinical.

#BCI#Depression#Mental Health Tech#Germany#Europe

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items — updated daily.

Start free trial
Already a member? Sign in